Stock Fundamentals

Company Information

Company Name
Tenaya Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US87990A1060
CIK: 0001858848
CUSIP: 87990A106
Currency: USD
Full Time Employees: 70
Phone: 650 825 6990
Fiscal Year End: December
IPO Date: Jul 30, 2021
Description:

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Address:

171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Directors & Officers

Name Title Year Born
Mr. Faraz Ali M.B.A. CEO, Interim Principal Financial Officer & Director 1973
Dr. Deepak Srivastava M.D. Scientific Founder, Chairman of Scientific Advisory Board & Director 1967
Dr. Whittemore G. Tingley M.D., PH.D. Chief Medical Officer 1968
Dr. Eric N. Olson Ph.D. Scientific Founder & Member of Scientific Advisory Board NA
Dr. Bruce R. Conklin M.D. Scientific Founder NA
Dr. Saptarsi Haldar M.D. Scientific Founder NA
Dr. Sheng Ding Ph.D. Scientific Founder NA
Dr. Benoit G. Bruneau Ph.D. Scientific Founder NA
Mr. Tomohiro Higa M.B.A. Senior Vice President of Finance & Interim Principal Accounting Officer 1969
Dr. Kee-Hong Kim Ph.D. Chief Technology Officer 1966

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 25, 2026 Group Gp Lp Column III N/A Sale 3.51M $0.56 $1.97M
Feb 24, 2026 Group Gp Lp Column III N/A Sale 658.44K $0.62 $408.23K
Feb 17, 2026 Faraz Ali N/A Sale 14.86K $0.64 $9.51K
Feb 17, 2026 Tomohiro Higa N/A Sale 3.47K $0.64 $2.22K
Feb 17, 2026 Whittemore Tingley N/A Sale 5.16K $0.64 $3.30K
Feb 11, 2026 Group Gp Lp Column III N/A Sale 4.06M $0.68 $2.76M
Feb 10, 2026 Group Gp Lp Column III N/A Sale 343.72K $0.82 $281.85K
Nov 17, 2025 Faraz Ali N/A Sale 3.13K $1.33 $4.16K
Nov 17, 2025 Tomohiro Higa N/A Sale 1.37K $1.33 $1.82K
Nov 17, 2025 Whittemore Tingley N/A Sale 2.88K $1.33 $3.83K
Aug 18, 2025 Faraz Ali N/A Sale 14.53K $1.25 $18.17K
Aug 18, 2025 Tomohiro Higa N/A Sale 2.96K $1.25 $3.70K
Aug 18, 2025 Whittemore Tingley N/A Sale 5.05K $1.25 $6.32K
May 16, 2025 Faraz Ali N/A Sale 3.19K $0.44 $1.40K
May 16, 2025 Tomohiro Higa N/A Sale 1.39K $0.44 $611.60
May 16, 2025 Whittemore Tingley N/A Sale 2.94K $0.44 $1.29K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 8.56M Dec 31, 2025 3.94% $0.00 69.01%
Vanguard Capital Management, LLC 8.48M Mar 31, 2026 3.91% $0.00 0.00%
Millennium Management LLC 5.46M Mar 31, 2026 2.51% $0.00 18.22%
Empery Asset Management, LP 4.29M Mar 31, 2026 1.98% $3.58 -20.82%
Citadel Advisors Llc 4.20M Mar 31, 2026 1.94% $0.00 0.00%
Kalehua Capital Management LLC 4.00M Mar 31, 2026 1.84% $1.07 100.00%
Renaissance Technologies Corp 3.71M Mar 31, 2026 1.71% $0.00 100.65%
BlackRock Inc 3.70M Mar 31, 2026 1.71% $0.00 -6.20%
Marshall Wace Asset Management Ltd 2.71M Mar 31, 2026 1.25% $0.00 92.41%
Burkehill Global Management, LP 2.00M Mar 31, 2026 0.92% $0.07 0.00%
Geode Capital Management, LLC 1.56M Mar 31, 2026 0.72% $0.00 30.72%
ADAR1 Capital Management LLC 1.51M Mar 31, 2026 0.69% $0.06 0.17%
Two Sigma Investments LLC 1.28M Mar 31, 2026 0.59% $0.00 1.13%
Jane Street Group LLC 1.18M Mar 31, 2026 0.54% $0.00 73.94%
GSA Capital Partners LLP 1.07M Mar 31, 2026 0.49% $0.05 -27.44%
Euclidean Capital LLC 1.02M Mar 31, 2026 0.47% $0.18 0.00%
Vanguard Fiduciary Trust Co 1.02M Mar 31, 2026 0.47% $0.00 0.00%
Raiffeisen Bank International AG 1.00M Mar 31, 2026 0.46% $0.01 11.11%
Alphabet Inc 915.71K Mar 31, 2026 0.42% $0.02 0.00%
Mirador Capital Partners LP 886.92K Mar 31, 2026 0.41% $0.09 52.25%

Shares Statistics

Shares Outstanding: 217.00M
Shares Float: 216.07M
% Insiders: 46.60%
% Institutions: 4,837.80%
Short % Float: 17.56%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 6.48M 2.98% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 1.77M 0.82% ▲ 0.00% Apr 30, 2026
3 Raiffeisen-Health&Wellbeing-ESG Akt A 1.20M 0.55% ▲ 20.00% Apr 30, 2026
4 iShares Biotechnology ETF 1.17M 0.54% ▲ 1.95% May 29, 2026
5 Fidelity Extended Market Index 714.40K 0.33% ▲ 17.22% Apr 30, 2026
6 Extended Equity Market Fund E 344.72K 0.16% ▲ 0.00% Dec 31, 2025
7 Extended Equity Market Fund B 344.72K 0.16% ▲ 0.00% Dec 31, 2025
8 Blackrock Extended Mkt Fund CF 344.72K 0.16% ▲ 0.00% Apr 30, 2026
9 Fidelity Total Market Index 303.13K 0.14% ▲ 29.10% Apr 30, 2026
10 BlackRock Extended Equity Market Fund K 293.52K 0.14% ▼ 0.73% Mar 31, 2026

Valuation Metrics

Enterprise Value: $82.32M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $154.46M
EBITDA: $-78.32M
Book Value: $0.57
Earnings/Share: $-0.44
Profit Margin: 0.00%
Operating Margin: -8,917.78%
ROA (TTM): -38.46%
ROE (TTM): -73.59%
Revenue (TTM): $225.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.84x 0.02x 0.16x N/A -0.04x
2024-12-31 4.22x 0.03x 0.23x N/A -0.03x
2023-12-31 4.91x 0.03x 0.18x N/A -0.04x
2022-12-31 7.99x 0.02x 0.13x -64,223.42x -0.03x
2021-12-31 11.73x 0.01x 0.12x -1.00x -0.03x
2020-12-31 25.78x 0.00x 0.06x N/A 0.00x
2019-12-31 6.73x 0.00x 2.15x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TNYA.US!